Compare TRDA & BGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TRDA | BGS |
|---|---|---|
| Founded | 2016 | 1996 |
| Country | United States | United States |
| Employees | N/A | 86 |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 275.3M | 297.1M |
| IPO Year | 2021 | 2004 |
| Metric | TRDA | BGS |
|---|---|---|
| Price | $6.21 | $3.09 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 5 |
| Target Price | ★ $21.00 | $4.90 |
| AVG Volume (30 Days) | 290.0K | ★ 2.0M |
| Earning Date | 05-08-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 14.34% |
| EPS Growth | N/A | ★ 83.02 |
| EPS | N/A | ★ N/A |
| Revenue | $25,421,000.00 | ★ $1,828,687,000.00 |
| Revenue This Year | $39.97 | N/A |
| Revenue Next Year | $50.80 | $0.52 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.56 | $2.87 |
| 52 Week High | $16.45 | $6.38 |
| Indicator | TRDA | BGS |
|---|---|---|
| Relative Strength Index (RSI) | 36.70 | 40.57 |
| Support Level | $5.71 | $2.87 |
| Resistance Level | $7.89 | $3.75 |
| Average True Range (ATR) | 0.39 | 0.11 |
| MACD | -0.09 | 0.01 |
| Stochastic Oscillator | 13.85 | 45.45 |
Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.
B&G Foods Inc manufactures, sells, and distributes a range of branded, shelf-stable, and frozen food and household products across the United States, Canada, and Puerto Rico. Its products include frozen and canned vegetables, canola and other cooking oils, vegetable shortening, cooking sprays, oatmeal and other hot cereals, fruit spreads, canned meats and beans, bagel chips, spices, seasonings, hot sauces, and wine vinegar. The company's main brands include Crisco, Clabber Girl, Bear Creek, Polaner, Underwood, B&G, Grandma's, New York Style, B&M, Baker's Joy, Regina, TrueNorth, Static Guard, SugarTwin and Brer Rabbit. It operates in four reportable segments: i) Specialty, the majoriy revenue generating segment, ii) Meals, iii) Frozen & Vegetables, iv) Spices & Flavor Solutions.